Thymosin α-1
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Thymosin α-1, covering 2021-12-10 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC [Phase 2]